Osaic Holdings’s Kyverna Therapeutics KYTX Stock Holding History

Osaic Holdings’s Portfolio KYTX Stock Details KYTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$35.1K	Buy	3,940 +3,215	+443%	+$28.5K	﹤0.01%	5738
2026 Q1	$6.26K	Sell	725 -2,500	-78%	-$20.8K	﹤0.01%	6566
2025 Q4	$30.3K	Buy	3,225 +725	+29%	+$5.38K	﹤0.01%	5583
2025 Q3	$14.8K	Hold	2,500	–	–	﹤0.01%	6124
2025 Q2	$7.67K	Sell	2,500 -2,500	-50%	-$6.18K	﹤0.01%	6314
2025 Q1	$9.65K	Buy	5,000 +2,822	+130%	+$8.34K	﹤0.01%	5803
2024 Q4	$8.15K	Sell	2,178 -2	-0.1%	-$10	﹤0.01%	5913
2024 Q3	$10.7K	Hold	2,180	–	–	﹤0.01%	5781
2024 Q2	$16.4K	Buy	2,180 +180	+9%	+$2.75K	﹤0.01%	5478
2024 Q1	$49.7K	Buy	+2,000	New	+$55.8K	﹤0.01%	4759

Other funds holding KYTX

GGI

GordonMD Global Investments Beverely Hills, California $207M AUM

Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

IHG

Insight Holdings Group New York $1.32B AUM 1.62% 1-Year Est. Return

Osaic Holdings's KYTX Position: Q2 2026 in Review

Osaic Holdings increased its Kyverna Therapeutics (KYTX) stake by 443% in Q2 2026, buying an estimated $28.5K and bringing the position to 3,940 shares worth $35.1K. The position accounts for ﹤0.01% of the portfolio, ranked #5738.

Osaic Holdings first reported a position in KYTX in Q1 2024 and has held it in 10 quarters since. The position peaked at $49.7K in Q1 2024. 120 funds tracked by Wall St. Rank hold KYTX as of Q2 2026.

Osaic Holdings held 3,940 shares of Kyverna Therapeutics worth $35.1K as of Q2 2026.
Osaic Holdings bought 3,215 Kyverna Therapeutics shares in Q2 2026, an estimated $28.5K.
Kyverna Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #5738 holding.
Osaic Holdings first reported a position in Kyverna Therapeutics in Q1 2024 and has held it in 10 quarters since.
Osaic Holdings's Kyverna Therapeutics position peaked at $49.7K in Q1 2024.
120 funds tracked by Wall St. Rank held Kyverna Therapeutics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.